<!DOCTYPE html>
<html>
<head>
<meta http-equiv="X-UA-Compatible" content="IE=Edge" />
<meta charset="utf-8" />
</head>

<body style="margin: 0;">

<div id="p82" style="overflow: hidden; position: relative; background-color: white; width: 935px; height: 1210px;">

<!-- Begin shared CSS values -->
<style class="shared-css" type="text/css" >
.t {
	transform-origin: bottom left;
	z-index: 2;
	position: absolute;
	white-space: pre;
	overflow: visible;
	line-height: 1.5;
}
.text-container {
	white-space: pre;
}
@supports (-webkit-touch-callout: none) {
	.text-container {
		white-space: normal;
	}
}
</style>
<!-- End shared CSS values -->


<!-- Begin inline CSS -->
<style type="text/css" >

#t1_82{left:119px;bottom:1134px;letter-spacing:0.11px;word-spacing:0.02px;}
#t2_82{left:808px;bottom:1132px;letter-spacing:-0.08px;}
#t3_82{left:141px;bottom:1081px;letter-spacing:0.15px;word-spacing:-0.59px;}
#t4_82{left:162px;bottom:1060px;letter-spacing:0.14px;}
#t5_82{left:162px;bottom:1025px;letter-spacing:0.12px;word-spacing:0.03px;}
#t6_82{left:243px;bottom:1033px;letter-spacing:-0.03px;}
#t7_82{left:255px;bottom:1025px;letter-spacing:0.12px;word-spacing:0.03px;}
#t8_82{left:379px;bottom:1033px;}
#t9_82{left:384px;bottom:1025px;letter-spacing:0.11px;word-spacing:0.03px;}
#ta_82{left:468px;bottom:1033px;}
#tb_82{left:473px;bottom:1025px;letter-spacing:0.12px;word-spacing:0.03px;}
#tc_82{left:612px;bottom:1033px;}
#td_82{left:617px;bottom:1025px;letter-spacing:0.11px;word-spacing:0.03px;}
#te_82{left:710px;bottom:1033px;}
#tf_82{left:162px;bottom:1016px;}
#tg_82{left:167px;bottom:1008px;letter-spacing:0.12px;word-spacing:0.48px;}
#th_82{left:162px;bottom:990px;letter-spacing:0.1px;}
#ti_82{left:212px;bottom:998px;}
#tj_82{left:217px;bottom:990px;letter-spacing:0.13px;word-spacing:3.36px;}
#tk_82{left:162px;bottom:972px;letter-spacing:0.12px;word-spacing:0.03px;}
#tl_82{left:162px;bottom:937px;letter-spacing:0.12px;}
#tm_82{left:252px;bottom:937px;letter-spacing:0.11px;word-spacing:0.17px;}
#tn_82{left:162px;bottom:920px;letter-spacing:0.12px;word-spacing:5.33px;}
#to_82{left:162px;bottom:902px;letter-spacing:0.12px;word-spacing:3.5px;}
#tp_82{left:162px;bottom:883px;letter-spacing:0.11px;word-spacing:0.02px;}
#tq_82{left:162px;bottom:865px;letter-spacing:0.12px;word-spacing:-0.43px;}
#tr_82{left:322px;bottom:865px;letter-spacing:0.1px;word-spacing:-0.44px;}
#ts_82{left:162px;bottom:848px;letter-spacing:0.11px;word-spacing:0.22px;}
#tt_82{left:162px;bottom:830px;letter-spacing:0.12px;word-spacing:1.73px;}
#tu_82{left:162px;bottom:813px;letter-spacing:0.11px;word-spacing:1.17px;}
#tv_82{left:162px;bottom:795px;letter-spacing:0.11px;word-spacing:0.03px;}
#tw_82{left:162px;bottom:778px;letter-spacing:0.1px;}
#tx_82{left:219px;bottom:778px;letter-spacing:0.11px;word-spacing:0.47px;}
#ty_82{left:162px;bottom:760px;letter-spacing:0.11px;word-spacing:-0.87px;}
#tz_82{left:162px;bottom:743px;letter-spacing:0.11px;word-spacing:2.08px;}
#t10_82{left:162px;bottom:725px;letter-spacing:0.12px;word-spacing:0.62px;}
#t11_82{left:162px;bottom:707px;letter-spacing:0.12px;word-spacing:3.84px;}
#t12_82{left:162px;bottom:690px;letter-spacing:0.11px;word-spacing:0.67px;}
#t13_82{left:162px;bottom:672px;letter-spacing:0.11px;word-spacing:0.03px;}
#t14_82{left:162px;bottom:655px;letter-spacing:0.12px;word-spacing:1.56px;}
#t15_82{left:350px;bottom:655px;letter-spacing:0.11px;word-spacing:1.56px;}
#t16_82{left:162px;bottom:637px;letter-spacing:0.11px;word-spacing:0.07px;}
#t17_82{left:162px;bottom:619px;letter-spacing:0.11px;word-spacing:0.02px;}
#t18_82{left:162px;bottom:602px;letter-spacing:0.14px;}
#t19_82{left:299px;bottom:602px;letter-spacing:0.12px;word-spacing:1.52px;}
#t1a_82{left:162px;bottom:585px;letter-spacing:0.12px;word-spacing:0.03px;}

.s0_82{font-size:15px;font-family:TimesNewRomanPSMT_6e;color:#000;}
.s1_82{font-size:17px;font-family:Calibri_7k;color:#000;}
.s2_82{font-size:18px;font-family:TimesNewRomanPS-BoldMT_7w;color:#000;}
.s3_82{font-size:15px;font-family:TimesNewRomanPS-BoldMT_7s;color:#000;}
.s4_82{font-size:10px;font-family:TimesNewRomanPS-BoldMT_8j;color:#000;}
.s5_82{font-size:10px;font-family:TimesNewRomanPSMT_87;color:#000;}
</style>
<!-- End inline CSS -->

<!-- Begin embedded font definitions -->
<style id="fonts82" type="text/css" >

@font-face {
	font-family: Calibri_7k;
	src: url("fonts/Calibri_7k.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7s;
	src: url("fonts/TimesNewRomanPS-BoldMT_7s.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_7w;
	src: url("fonts/TimesNewRomanPS-BoldMT_7w.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPS-BoldMT_8j;
	src: url("fonts/TimesNewRomanPS-BoldMT_8j.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_6e;
	src: url("fonts/TimesNewRomanPSMT_6e.woff") format("woff");
}

@font-face {
	font-family: TimesNewRomanPSMT_87;
	src: url("fonts/TimesNewRomanPSMT_87.woff") format("woff");
}

</style>
<!-- End embedded font definitions -->

<!-- Begin page background -->
<div id="pg82Overlay" style="width:100%; height:100%; position:absolute; z-index:1; background-color:rgba(0,0,0,0); -webkit-user-select: none;"></div>
<div id="pg82" style="-webkit-user-select: none;"><object width="935" height="1210" data="82/82.svg" type="image/svg+xml" id="pdf82" style="width:935px; height:1210px; -moz-transform:scale(1); z-index: 0;"></object></div>
<!-- End page background -->


<!-- Begin text definitions (Positioned/styled in CSS) -->
<div class="text-container"><span id="t1_82" class="t s0_82">Brain: Chemistry to Cognition </span><span id="t2_82" class="t s1_82">74 </span>
<span id="t3_82" class="t s2_82">OR2.10.  Outcome of EP2 antagonist treatment to a two-hit mouse model of Alzheimer’s </span>
<span id="t4_82" class="t s2_82">disease depends on the mouse strain and the sex </span>
<span id="t5_82" class="t s3_82">Avijit Banik </span>
<span id="t6_82" class="t s4_82">1,2 </span>
<span id="t7_82" class="t s0_82">, Radhika Amaradhi </span>
<span id="t8_82" class="t s5_82">1 </span>
<span id="t9_82" class="t s0_82">, Michael Sau </span>
<span id="ta_82" class="t s5_82">1 </span>
<span id="tb_82" class="t s0_82">, Raymond Dingledine </span>
<span id="tc_82" class="t s5_82">1 </span>
<span id="td_82" class="t s0_82">, Thota Ganesh </span>
<span id="te_82" class="t s5_82">1 </span>
<span id="tf_82" class="t s4_82">1 </span>
<span id="tg_82" class="t s0_82">Department of Pharmacology and Chemical Biology, School of Medicine, Emory University. Atlanta, GA </span>
<span id="th_82" class="t s0_82">30322; </span>
<span id="ti_82" class="t s5_82">2 </span>
<span id="tj_82" class="t s0_82">Department of Biotechnology, GITAM School of Science, GITAM deemed to be University, </span>
<span id="tk_82" class="t s0_82">Visakhapatnam, AP 530045 </span>
<span id="tl_82" class="t s3_82">Background: </span><span id="tm_82" class="t s0_82">Alzheimer’s disease (AD) is the largest spectrum of dementia, and is a chronic condition that </span>
<span id="tn_82" class="t s0_82">severely impairs memory, thinking, and social abilities, negatively impacting the daily life of the </span>
<span id="to_82" class="t s0_82">Prostaglandin-E2 (PGE2) receptor EP2, which is activated downstream of cyclooxygenase-2 (COX-2) </span>
<span id="tp_82" class="t s0_82">signaling, emerged as a neuroinflammatory target in several neurodegenerative diseases including AD. </span>
<span id="tq_82" class="t s3_82">Materials and Methods: </span><span id="tr_82" class="t s0_82">Here we investigated the effect of a selective EP2 antagonist on behavioral deficits </span>
<span id="ts_82" class="t s0_82">in 5xFAD transgenic mice subjected to mild, systemic inflammation by lipopolysaccharide (LPS). We have </span>
<span id="tt_82" class="t s0_82">exposed a cohort of 5xFAD mice in C57BL/6 and B6SJL backgrounds with once-a-week intraperitoneal </span>
<span id="tu_82" class="t s0_82">injection of LPS (0.5 mg/kg or 1 mg/kg) and treated with either vehicle or EP2 antagonist TG11-77. HCl </span>
<span id="tv_82" class="t s0_82">(100 mg/kg/day) for 12 weeks in drinking water. </span>
<span id="tw_82" class="t s3_82">Results: </span><span id="tx_82" class="t s0_82">Complete blood count (CBC) analysis was performed to demonstrate that LPS induced an anemia </span>
<span id="ty_82" class="t s0_82">of inflammation, and induction of inflammatory gene expression (mRNA) in these mice brains. TG11-77.HCl </span>
<span id="tz_82" class="t s0_82">improves memory retention both in single hit – environmental and two hit mice. Further, TG11-77.HCl </span>
<span id="t10_82" class="t s0_82">ameliorates mRNA expression of many proinflammatory chemokines and cytokines in two-hit male cortex </span>
<span id="t11_82" class="t s0_82">in B6SJL backgrounds while females showed significant improvement in C57BL/6 strains. This was </span>
<span id="t12_82" class="t s0_82">corroborated by attenuated amyloid pathology in two-hit B6SJL male brain, but no alteration was found in </span>
<span id="t13_82" class="t s0_82">female brains in C57BL/6 mice. </span>
<span id="t14_82" class="t s3_82">Discussion and Conclusion: </span><span id="t15_82" class="t s0_82">This study reveals that EP2 antagonism is a prudent therapeutic strategy in </span>
<span id="t16_82" class="t s0_82">reducing brain inflammation and behavioral deficits in Alzheimer’s brain when it is subjected to an external </span>
<span id="t17_82" class="t s0_82">secondary hit of neuroinflammation. But these outcomes are strain and sex specific. </span>
<span id="t18_82" class="t s3_82">Acknowledgements: </span><span id="t19_82" class="t s0_82">This study was supported by the NIH funds NIA Grant: U01AG052460 (T.G.) and </span>
<span id="t1a_82" class="t s0_82">NINDS Grant: R21/R33 NS101167 (T.G.). </span></div>
<!-- End text definitions -->


</div>
</body>
</html>
